Dvago Logo
    location icon


    Breavant 200 Rotacaps 30S

    Rs. 570.00

    Rs. 600.00




    Requires Prescription (YES/NO)




    Used For


    How it works

    Salbutamol is a selective beta2 adrenoceptor agonist. At therapeutic doses it acts on the beta2 adrenoceptors of bronchial muscle providing short acting (4 to 6 hour) bronchodilation in reversible airways obstruction.




    Side Effects

    Immune system disorders - Very rare: Hypersensitivity reactions including angioedema, urticaria, bronchospasm, hypotension and collapse.Metabolism and nutrition disorders - Rare: Hypokalaemia. Potentially serious hypokalaemia may result from beta2 agonist therapy.Nervous system disorders - Very common: Tremor. Common: Headache. Very rare: Hyperactivity.Cardiac disorders - Common: Tachycardia, palpitations. Rare: Cardiac arrhythmias including atrial fibrillation, supraventricular tachycardia and extrasystoles.Vascular disorders- Rare: Peripheral vasodilatation.Musculoskeletal and connective tissue disorders - Common: Muscle cramps. Very rare: Feeling of muscle tension.

    Drug Interactions

    Propranolol , monoamine oxidase inhibitors (MAOIs) , digoxin , theophylline or aminophylline) , prednisolone , (such as frusemide) , such as insulin, metformin or glibenclamide .


    Salbutamol are indicated for the relief of bronchospasm in bronchial asthma of all types, chronic bronchitis and emphysema.

    When not to Use

    It is contra-indicated in patients with a history of hypersensitivity to any of their components. Non-i.v. formulations of must not be used to arrest uncomplicated premature labour or threatened abortion.



    Potentially serious hypokalaemia may result from beta2 agonist . Particular caution is advised in acute severe asthma as this effect may be potentiated by concomitant treatment with xanthine derivatives, steroids, diuretics and by hypoxia. It is recommended that serum potassium levels are monitored in such situations.Therapy mainly from parenteral and nebulised administration.


    Warning 1

    The management of asthma should normally follow a stepwise programme, and patient response should be monitored clinically and by lung function tests

    Warning 2

    Increasing use of short-acting inhaled beta2 agonists to control symptoms indicates deterioration of asthma control. Under these conditions, the patient's therapy plan should be reassessed. Sudden and progressive deterioration in asthma control is potentially lifethreatening and consideration should be given to starting or increasing corticosteroid therapy. In patients considered at risk, daily peak flow monitoring may be instituted.

    Warning 3

    Patients should be warned that if either the usual relief is diminished or the usual duration of action reduced, they should not increase the dose or its frequency of administration, but should seek medical advice.


    Pregnancy category

    Always consult your physician before using any medicine.

    Storage (YES/NO)

    Store this medicine at room temperature, away from direct light and heat.

    Related Products